News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

Incyte (INCY) Jazz Pharmaceuticals (JAZZ) Prosensa (RNA) ImmunoGen (IMGN) Idenix (IDIX) Illumina (ILMN) ARCA (ABIO) VANDA (VNDA) HALOZYME (HALO) Multiple Myeloma NEKTAR (NKTR)) Anacor (ANAC) Intrexon (XON) Inovio (INO) Array Pharmaceuticals (ARRY) Herceptin Onyx (ONXX) SUNESIS PHARMACEUTICALS (SNSS) Theravance (THRX) Sangamo (SGMO) AERIE PHARMACEUTICALS Agenus (AGEN) SYNTA (SNTA) Dendreon (DNDN) galapagos (GLPG) Pluristem (PSTI) IDERA (IDRA) C4 Therapeutics Trastuzumab-DM1 Human Genome Sciences (HGSI) GlaxoSmithKline (GSK) Galena (GALE) Merck (MRK) Sarepta (SRPT) ADVENTRIX (ANX) Rapamune KITE (KITE) Benlysta (belimumab) Mirati Therapeutics (MRTX) NANTKWEST (NK) Tysabri Endometrial Cancer ABBVIE (ABBV) OSI (OSIP) Elan (ELN) Sanofi (SNA) Auspex (ASPX) Gilead (GILD) GUARDIAN HEALTH Roche (ROCHE) BIOMARIN (BMRN) Telaprevir Exelixis (EXEL) Valeant Pharmaceuticals International (VRX) Micromet (MITI) Ziofpharm (ZIOP) Regeneron (REGN) Revlimid (lenolidamide) Agenus (AGEN Roche (RHHBY) Abbott Laboratories (ABT) Alnylam (ALNY) JUNO (JUNO) Ariad (ARIA) Biocryst (BCRX) ISIS (ISIS) Sanofi (SNY) Biogen Idec (BIIB) Aimmune Therapeutics (AIMT) ZALTRAP™ Vertex (VRTX) Prolor Biotech (PBTH) Intercept (ICPT) Intermune (ITMN) Genentech Amgen (AMGN) SERES THERAPEUTICS (MCRB) Dynavax (DVAX) Sanofi-Aventis (SAN) Anadys (ANDS) Xoma (XOMA) TOKAI (TKAOI) Ridaforolimus Cytokinetics (CYTK) CompuGen (CGEN) Seattle Genetics (SGEN) Zerenex Sequenom (SQNM) Bristol-Myers Squibb (BMY) Velcade (bortezomib) KERYX (KERX)